Company: MIRA
Filing Date: 2025-12-05
Form Type: 8-K
Source: 0001493152-25-026445
Chunk: 1

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-12-05
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item
9.01. Financial Statements and Exhibits.

(d)
Exhibits

  Exhibit      Description                                                               
      No.                                                                                
 ─────────────────────────────────────────────────────────────────────────────────────────
     5.01      Opinion of Pearl Cohen Zedek Latzer Baratz LLP                            
     23.1      Consent of Pearl Cohen Zedek Latzer Baratz LLP (included in Exhibit 5.1)  
      104      Cover                                                                     

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                        MIRA                                          
  Dated:                By:                        /s/                
                        Name:                      Erez               
                        Title:                     Chief